Inhouse product
DAIBEND is a
scientifically developed Ayurvedic proprietary medicine by Ajivan,
formulated to support healthy pancreatic function, balance insulin production,
and regulate blood sugar levels naturally. Along with supporting sugar control,
these capsules also help improve metabolism, manage weight, and enhance overall
vitality for daily wellness.
Helps the pancreas
function optimally for better insulin response.
Promotes stable sugar levels
throughout the day.
Enhances metabolic
activity and supports better weight management.
Helps reduce tiredness
caused by fluctuating sugar levels.
Strengthens pancreatic
health and supports long-term balance.
Boosts energy levels
by improving cell function and nutrient absorption.
Supports overall
wellbeing when used regularly.
DAIBEND helps
strengthen the pancreas and maintains the body’s natural insulin balance. It
supports healthy blood pressure, regulates sugar levels, improves metabolism,
and boosts energy. Each capsule contains Ayurvedic herbs traditionally known
for their effectiveness in sugar management and wellness.
·
Ocimum
Sanctum (Tulsi) – 100 mg
·
Foeniculum
Vulgare (Saunf) – 100 mg
·
Azadirachta
Indica (Neem) – 100 mg
·
Tinospora
Cordifolia (Giloy) – 100 mg
·
Gymnema
Sylvestre (Gudmar) – 50 mg
·
Yasad
Bhasma – 50 mg
·
Excipients
– q.s.
These herbs support
insulin sensitivity, reduce sugar absorption, enhance immunity, and promote
healthy metabolic function.
·
Take 1–2
capsules twice daily
·
Or as recommended
by your physician
·
Keep away from
children
·
Do not use if the
seal is damaged
·
Store in a cool,
dry place
·
Individuals with high
or fluctuating blood sugar
·
People in a pre-diabetic
stage
·
Those
experiencing weakness, fatigue, or slow metabolism
·
Anyone looking
for a natural Ayurvedic sugar-control solution
✔ 100%
Ayurvedic proprietary formulation
✔ Made from high-quality
herbs
✔ Free from harmful
chemicals
✔ Safe for long-term use
✔ Trusted by thousands of
customers
Login Or Registerto submit your questions to seller
No none asked to seller yet